Home NDC 53002-2630 Ella
Product NDC 53002-2630
11-digit product format 530022630
Labeler code 53002
Product ID 53002-2630_28822df7-626a-43a0-8648-7ca0cc7b5c0a
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name ulipristal acetate
Dosage form TABLET
Route ORAL
Labeler RPK Pharmaceuticals, Inc.
Application NDA022474
Marketing category NDA
Marketing start 2020-05-11
Marketing end 0000-00-00
Substance ULIPRISTAL ACETATE
Active strength 30 mg/1
Pharmacologic classes Progesterone Agonist/Antagonist [EPC], Selective Progesterone Receptor Modulators [MoA]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 18 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 53002-2630-1 I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 53002-2630-1 I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 53002-2630-1 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 53002-2630-1 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 53002-2630-1 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 53002-2630-1 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product U Excluded because listing certification expired 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 53002-2630-1 U Excluded because listing certification expired 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product U Excluded because listing certification expired ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 53002-2630-1 U Excluded because listing certification expired ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product U Excluded because listing certification expired 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 53002-2630-1 U Excluded because listing certification expired 0efc9e666f02…f202fb6c5f17…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N022474-001 ELLA ULIPRISTAL ACETATE 30MG TABLET / ORAL AB RLD, RS 2010-08-13
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N022474-001 AB
Orange Book patents# Current patent rows page 1 of 1 · 8 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N022474-001 9844510 2028-12-08 Drug product 2019-04-18 N022474-001 8735380 2029-02-20 Drug product 2014-06-13 N022474-001 10159681 2030-04-13 U-2510 2019-04-18 N022474-001 10772897 2030-04-13 U-2958 2020-10-14 N022474-001 9283233 2030-04-13 U-1821 2016-03-16 N022474-001 8512745 2030-06-02 Drug product 2013-09-12 N022474-001 8426392 2030-06-12 U-1389 2013-05-07 N022474-001 8962603 2030-06-12 U-1657 2015-02-25
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N022474-001 ELLA 30MG TABLET / ORAL AB RLD, RS 2010-08-13 e64feba35796…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 42 observed states.
Observed Orange Book patent history# Patent history page 1 of 9 · 331 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-18 06:07:40 2026-07 N022474-001 9844510 2028-12-08 Drug product 2019-04-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022474-001 8735380 2029-02-20 Drug product 2014-06-13 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022474-001 10159681 2030-04-13 U-2510 2019-04-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022474-001 10772897 2030-04-13 U-2958 2020-10-14 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022474-001 9283233 2030-04-13 U-1821 2016-03-16 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022474-001 8512745 2030-06-02 Drug product 2013-09-12 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022474-001 8426392 2030-06-12 U-1389 2013-05-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022474-001 8962603 2030-06-12 U-1657 2015-02-25 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N022474-001 9844510 2028-12-08 Drug product 2019-04-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022474-001 8735380 2029-02-20 Drug product 2014-06-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022474-001 10159681 2030-04-13 U-2510 2019-04-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022474-001 10772897 2030-04-13 U-2958 2020-10-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022474-001 9283233 2030-04-13 U-1821 2016-03-16 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022474-001 8512745 2030-06-02 Drug product 2013-09-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022474-001 8426392 2030-06-12 U-1389 2013-05-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022474-001 8962603 2030-06-12 U-1657 2015-02-25 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022474-001 9844510 2028-12-08 Drug product 2019-04-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022474-001 8735380 2029-02-20 Drug product 2014-06-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022474-001 10159681 2030-04-13 U-2510 2019-04-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022474-001 10772897 2030-04-13 U-2958 2020-10-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022474-001 9283233 2030-04-13 U-1821 2016-03-16 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022474-001 8512745 2030-06-02 Drug product 2013-09-12 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022474-001 8426392 2030-06-12 U-1389 2013-05-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022474-001 8962603 2030-06-12 U-1657 2015-02-25 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022474-001 9844510 2028-12-08 Drug product 2019-04-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022474-001 8735380 2029-02-20 Drug product 2014-06-13 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022474-001 10159681 2030-04-13 U-2510 2019-04-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022474-001 10772897 2030-04-13 U-2958 2020-10-14 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022474-001 9283233 2030-04-13 U-1821 2016-03-16 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022474-001 8512745 2030-06-02 Drug product 2013-09-12 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022474-001 8426392 2030-06-12 U-1389 2013-05-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022474-001 8962603 2030-06-12 U-1657 2015-02-25 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022474-001 9844510 2028-12-08 Drug product 2019-04-18 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022474-001 8735380 2029-02-20 Drug product 2014-06-13 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022474-001 10159681 2030-04-13 U-2510 2019-04-18 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022474-001 10772897 2030-04-13 U-2958 2020-10-14 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022474-001 9283233 2030-04-13 U-1821 2016-03-16 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022474-001 8512745 2030-06-02 Drug product 2013-09-12 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022474-001 8426392 2030-06-12 U-1389 2013-05-07 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022474-001 8962603 2030-06-12 U-1657 2015-02-25 fd3edfee7708…
Observed Orange Book exclusivity history# DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 53002-2630-1 Ella 1 in 1 BLISTER PACK TABLET 1 1 53002-2630-1 Ella 1 in 1 CARTON TABLET 1 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 53002-2630 ELLA (ULIPRISTAL ACETATE) TABLET [RPK PHARMACEUTICALS, INC.] 1 Legacy NDC, 2 package rows 20220331_c775958f-9ea3-4a5c-9915-794d844e4024.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 53002-2630-1 53002263001 1 BLISTER PACK in 1 CARTON (53002-2630-1) > 1 TABLET in 1 BLISTER PACK 1 blister pack 2022-08-01 0000-00-00 No No Current